Basic information
Biomarker: Pirh2
Histology type: endometrial carcinoma
Cohort characteristics
Country: Egypt.
Region: Zagazig
Followed up time :
Subgroup 1 name : High Pirh2
Subgroup 1 number: 35
Subgroup 2 name: Low expression
Subgroup 2 number: 25
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 60 | EC | 60 |
Sample information
Conclusion: Mutant p53, high Pirh2, and L1CAM-positive EC are highly aggressive tumors with a shortened survival rate, dismal outcome, and high risk of relapse after the standard protocol of therapy.
Sample type : tissue
Sample method: immunohistochemistry (IHC) and polymerase chain reaction
Expression pattern : positive
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
